Stay up-to-date with the latest news and information from the drug testing industry by subscribing to Results, our monthly newsletter.
Your Privacy Choices | Privacy Notices | Privacy Shield | Terms | Language Assistance / Non-Discrimination Notice | Asistencia de Idiomas / Aviso de no Discriminación | 語言協助 / 不䈚視通知
Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks — ® and ™ — are the property of their respective owners. © 2000-2023 Quest Diagnostics Incorporated. All rights reserved.
The Arrestee Drug Abuse Monitoring II (ADAM II) uses statistically-sampled, volunteer arrestees to interview and provide urine specimens that are tested for evidence of drug use. Urinalysis results are matched to arrestee characteristics to help monitor trends in drug use. ADAM II provides an objective biological measure of drug use in addition to self-reported drug use among those arrested and charged with crimes.
According to the data found from ADAM II, Marijuana continues to be the most commonly detected drug among U.S. male arrestees; the percentage of arrestees testing positive for marijuana ranged from 37% to 58% across five states in 2012. Additionally, cocaine was the second most commonly detected drug in four of the five sites – although cocaine positives have declined significantly among arrestees in all sites over the last ten years.
CESAR FAX provides a weekly, one-page overview of timely substance abuse trends or issues. Read this latest issue for more information.
For more information about drug testing, visit our website.